ChartRow logo
Data provided bySource: Twelve Data
CCJ
$70.73-1.46%
as of close, Nov 13, 2026
☾ AH $70.73 -1.46%
PeersTECKWPMFNVBWXTFCXB
Share this page

CCJ financial statements

The full income statement, balance sheet, and cash-flow statement for Cameco Corporation (CCJ), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Financial overview#

Revenue

5Y CAGR +13.2%5Y CAGR +13.2%
$2.5B FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Gross profit

5Y CAGR +54.3%5Y CAGR +54.3%
$694.3M FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Operating income

5Y n/m5Y n/m
$442.4M FY25
FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Net income

5Y n/m5Y n/m
$421.9M FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

EPS (diluted)

5Y n/m5Y n/m
$0.97 FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Operating cash flow

5Y CAGR +88.4%5Y CAGR +88.4%
$1B FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Capital expenditure

5Y CAGR +32.8%5Y CAGR +32.8%
$238.3M FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Free cash flow

5Y n/m5Y n/m
$769.6M FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Shares (diluted)

5Y +10.0%5Y +10.0%
435.6M FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Dividend per share

5Y CAGR +23.6%5Y CAGR +23.6%
$0.17 FY25
FY16FY17FY18FY19FY20FY21FY22FY23FY24FY25

No quarters filed for this figure.

Every CCJ chart on Trends →

Shares outstanding (point-in-time)

2017-12 395.8M2018-12 395.8M2019-12 395.8M2020-12 396.3M2021-12 398.1M2022-12 432.5M2023-12 434.2M2024-12 435.3M2025-12 435.5M+10.0% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue2.49B+8.9%2.29B+19.3%1.92B+33.6%1.44B+22.0%1.18B-12.4%
694M+21.6%571M+37.1%416M+132.2%179M+11517.4%1.54M-98.1%
Cost of revenue1.80B+4.7%1.72B+14.3%1.50B+19.5%1.26B+6.9%1.18B-7.0%
Research & development27.5M+3.3%26.7M+71.0%15.6M+66.6%9.35M+63.6%5.72M+93.3%
Operating income442M+18.9%372M+77.5%210M+1712.6%11.6M+110.6%-109M-85.0%
Interest expense82.4M-23.2%107M+25.0%85.9M+30.4%65.9M+7.8%61.1M-14.8%
Pre-tax income556M+197.1%187M-48.1%361M+454.1%65.1M+178.6%-82.9M-181.0%
Income tax134M+117.0%61.9M-33.9%93.6M+2826.6%-3.43M-258.4%-958K-109.4%
422M+236.6%125M-53.1%267M+289.9%68.6M+183.7%-81.9M-106.4%
Net income to common422M+236.6%125M-53.1%267M+289.4%68.7M+183.9%-81.8M-106.3%
$0.97+239.6%$0.28-53.8%$0.62+263.9%$0.17+181.5%-$0.21-113.9%
EPS (basic)$0.97+231.1%$0.29-52.6%$0.62+263.9%$0.17+181.5%-$0.21-113.9%
Weighted-avg shares (basic)435M+0.1%435M+0.3%433M+6.9%405M+2.0%398M+0.5%
Weighted-avg shares (diluted)436M-0.1%436M+0.1%435M+6.9%407M+2.4%398M+0.5%
Dividends per share$0.17+47.2%$0.12+31.2%$0.09-3.5%$0.09+44.5%$0.06+7.1%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.93B+44.2%1.34B-3.9%1.39B-43.3%2.45B+44.8%1.70B+10.9%
Cash & equivalents814M+95.0%417M-2.5%428M-49.3%845M-14.4%987M+36.9%
Accounts receivable263M+9.1%241M-24.4%319M+134.8%136M-37.8%219M+35.7%
Inventory616M+7.2%575M+9.9%523M+6.5%491M+51.5%324M-39.4%
7.52B+9.2%6.89B-8.2%7.50B+17.7%6.38B+7.2%5.95B-0.1%
Property, plant & equipment2.43B+6.3%2.28B-10.2%2.54B-0.8%2.57B-9.4%2.83B-4.4%
Total non-current assets5.60B+0.8%5.55B-9.2%6.11B+55.8%3.92B-7.8%4.26B-3.9%
781M-5.2%824M-8.2%898M+116.8%414M+26.5%327M+37.2%
Short-term & current debt0.00-100.0%199M-47.4%378M0.00—
Long-term debt728M+5.1%692M-28.7%970M+31.7%737M-6.6%789M+0.8%
5.04B+13.9%4.42B-3.9%4.60B+6.8%4.31B+12.4%3.84B-1.5%
Total equity incl. non-controlling5.04B+13.9%4.42B-3.9%4.60B+6.8%4.31B+12.4%3.84B-1.5%
Common shares outstanding435M+0.0%435M+0.3%434M+0.4%433M+8.7%398M+0.5%
Shares outstanding (cover)435M+0.0%435M+0.3%434M+0.4%433M+8.7%398M+0.5%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
1.01B+52.6%660M+29.5%510M+117.9%234M-36.0%366M+761.5%
Depreciation & amortization210M+2.4%205M+25.4%163M+19.8%136M-10.3%152M-2.4%
Capital expenditure238M+54.4%154M+35.6%114M+3.3%110M+39.9%78.8M+36.4%
Free cash flow770M+52.1%506M+27.7%396M+219.9%124M-56.8%287M+1968.8%
Acquisitions0.000.000.000.000.00
Long-term debt issued0.00-100.0%363M-40.1%605M0.000.00-100.0%
Long-term debt repaid204M-73.1%760M0.000.000.00-100.0%
Common stock issued1.55M-87.2%12.1M-40.5%20.4M+175.7%7.40M-65.3%21.4M+432.6%
Common stock repurchased0.000.000.000.000.00
Dividends paid74.8M+47.2%50.8M+31.6%38.6M-3.2%39.9M+57.0%25.4M+7.6%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap39.8B+78.1%22.4B+20.0%18.6B+106.6%9.02B+3.9%8.68B+63.5%
P/E94.4×-47.1%178.5×-34.3%271.8×——
P/S16.0×+63.5%9.8×-24.7%13.0×+69.4%7.7×+3.9%7.4×+86.6%
P/B7.9×+56.3%5.1×+17.0%4.3×+83.8%2.4×+3.9%2.3×+66.0%
P/FCF51.8×+17.1%44.2×-70.6%150.6×+378.5%31.5×+3.9%30.3×
Earnings yield1.1%+89.0%0.56%+52.3%0.37%——
FCF yield1.9%-14.6%2.3%+240.5%0.66%-79.1%3.2%-3.8%3.3%
Dividend yield0.19%-17.3%0.23%+10.1%0.21%-49.3%0.41%+39.0%0.29%-34.2%
Source filing40-F40-F40-F40-F40-F

About this data

Source: CCJ’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all CCJ filings on SEC EDGAR → Not investment advice.